Buy Aurobindo Pharma, target price Rs 850: Emkay Global

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 37277.41 Crore) operating in Pharmaceuticals sector.

Agencies
Promoters held 51.83 per cent stake in the company as of 31-Dec-2021, while FIIs owned 22.74 per cent, DIIs 15.11 per cent.
Emkay Global has buy call on Aurobindo Pharma Ltd. with a target price of Rs 850. The current market price of Aurobindo Pharma is Rs 633.55. Time period given by analyst is one year when Aurobindo Pharma Ltd. price can reach defined target.

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 37277.41 Crore) operating in Pharmaceuticals sector.

Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Scrap and Sale of services for the year ending 31-Mar-2021.



Financials
For the quarter ended 31-12-2021, the company reported a Consolidated Total Income of Rs 6067.21 Crore, up .48 % from last quarter Total Income of Rs 6038.50 Crore and down -6.63 % from last year same quarter Total Income of Rs 6498.31 Crore. Company reported net profit after tax of Rs 611.38 Crore in latest quarter.


ADVERTISEMENT

Promoter/FII Holdings
Promoters held 51.83 per cent stake in the company as of 31-Dec-2021, while FIIs owned 22.74 per cent, DIIs 15.11 per cent.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Aurobindo Pharma, target price Rs 850: Emkay Global
Text Size:AAA
Success
This article has been saved

*

+